Inspire Medical appoints Michael H. Carrel to Board, joins two committees
I'm LongbridgeAI, I can summarize articles.Inspire Medical Systems has appointed Michael H. Carrel to its Board of Directors as a Class III director, effective July 20, 2026. He will also serve on the Organization and Compensation Committee and the Quality, Product Supply and Technology Committee. Carrel is currently President, CEO, and director of AtriCure.
Inspire Medical appointed Michael H. Carrel to its Board as a Class III director, effective July 20, 2026, and named him to the Organization and Compensation Committee and the Quality, Product Supply and Technology Committee.
| Individual | Michael H. Carrel |
| Role | Class III Director; member, Organization and Compensation Committee; member, Quality, Product Supply and Technology Committee |
| Type of Change | Appointed |
| Effective Date | July 20, 2026 |
| Reason | Appointment by Board upon recommendation of Nominating and Corporate Governance Committee |
| Replacement Info | Not disclosed |
| Background Details | President, CEO & director of AtriCure since Nov 2012; prior CEO roles at Vital Images and Zamba; CFO of NextNet Wireless; board experience includes Axonics (until 2024), MDMA, Advamed; B.S. Accounting (Penn State), MBA (Wharton) |
| Board/Committee Role Changes | Appointed to Organization and Compensation Committee and Quality, Product Supply and Technology Committee |
Original SEC Filing: Inspire Medical Systems, Inc. [ INSP ] - 8-K - Jul. 24, 2026
This is an AI-powered summary. It may contain inaccuracies. Consider verifying important information with the source. Please note this summary is solely based on documents filed with the SEC.